Wealth Enhancement Advisory Services’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Wealth Enhancement Advisory Services's IBRX Position: Q3 2026 in Review
Wealth Enhancement Advisory Services reduced its ImmunityBio (IBRX) stake by 0.36% in Q3 2026, selling an estimated $767 and leaving 26,238 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #3496.
Wealth Enhancement Advisory Services first reported a position in IBRX in Q2 2025 and has held it in 6 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Wealth Enhancement Advisory Services held 26,238 shares of ImmunityBio worth $260K as of Q3 2026.
- Wealth Enhancement Advisory Services sold 96 ImmunityBio shares in Q3 2026, an estimated $767.
- ImmunityBio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3496 holding.
- Wealth Enhancement Advisory Services first reported a position in ImmunityBio in Q2 2025 and has held it in 6 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.